Is it validated?
Does the marker have published, reproducible evidence linking it to a meaningful health outcome — or is it novelty dressed up as insight?
Blood panels, drips and hormone therapy are table stakes — every clinic offers them. Our advantage isn't what we offer, but the depth and honesty with which we deliver it. Four reinforcing pillars set us apart.
Most clinics in this space sit somewhere between an aesthetic spa with a drip menu and a private GP — and many lean on fear-based marketing or tests of questionable predictive value. We take the opposite position. Every panel we offer and every protocol we recommend is grounded in published evidence, and we're transparent about what each marker can and cannot tell you.
This is hard to imitate because it requires genuine scientific literacy. Our clinical leadership combines biochemistry research with prescriber oversight, letting us interpret results with a depth generalist clinics can't match.
Competitors sell tests as discrete events: pay, receive a PDF, relationship ends. We treat each member as a continuous physiological dataset. Every retest is plotted against your own baseline, trends are tracked over time, and a clinician who knows your history flags meaningful changes early.
The product is the longitudinal record and the ongoing clinical relationship — not the individual test. Physiology is best understood as a trajectory, not a single point.
The sector's credibility problem is driven by overpromising. We turn that into an advantage by doing the opposite: publishing our pricing openly, explaining when a test isn't worth doing, and telling clients when they don't need to spend more. Advising someone against a purchase is one of the most powerful retention and referral tools there is.
Every therapy is delivered under a documented governance framework by GMC-registered clinicians and appropriate prescribers. We work only within what UK regulation permits, guided by specialist healthcare legal advice — no grey-market shortcuts.
Depth of view
A standard physical rarely goes past TSH, a basic lipid panel and a full blood count. We look at the systems that actually predict long-term risk — and the sub-markers that reveal it early.
How we decide
Does the marker have published, reproducible evidence linking it to a meaningful health outcome — or is it novelty dressed up as insight?
If the result comes back abnormal, is there a real, evidence-based intervention we can offer? If not, we won't order it.
Your history, goals and risk profile decide the panel. We build the test around the person — never the other way around.
An honest consultation is the best way to see how we work. If testing isn't right for you yet, we'll say so.
Join the waitlist